References
Blessing K, McLaren KM, McLean A, Davidson P (1990) Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis. Histopathology 17:389–395
Bröcker E-B, Macher E, Sorg C (1990) Changes in the tumour-associated inflammatory infiltrates in the course of local and systemic progression of cutaneous melanoma. In: Ferrone S (ed) Human melanoma. Springer, Berlin Heidelberg New York, pp 278–293
Clark WH, Elder DE, Dupont G, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC (1989) Model predicting survival in Stage 1 melanoma based on tumour progression. J Natl Cancer Inst 81:1893–1904
Cooper PH, Wanebo HJ, Ward Hagar R (1985) Regression in thin malignant melanoma. Arch Dermatol 121:1127–1131
Day CL, Mihm MC, Lew RA, et al. (1982) Prognostic factors for patients with clinical stage 1 melanoma of intermediate thickness (1.51–3.99 mm). Ann Surg 195:35–43
Drzewiecki KT, Andersen PK (1982) Survival with malignant melanoma. A regression analysis of prognostic factors. Cancer 49:2414–2419
Gromet MA, Epstein WL, Blois MS (1978) The regressing thin malignant melanoma. A distinctive lesion with metastatic potential. Cancer 42:2282–2292
Johnson JP, Stade BG, Rothbächer U, Lehmann JM, Riethmüller G (1990) Melanoma antigens and their association with malignant transformation and tumour progression. In: Ferrone S (ed) Human melanoma. Springer, Berlin Heidelberg New York, pp 106–118
Kelly JW, Sagebiel RW, Blois MS (1985) Regression in malignant melanoma. A histologic feature without independent prognostic significance. Cancer 56:2287–2291
Kopf AW, Welkovich B, Frankel RE, Stoppelmann EJ, Bart RS, Rogers GS, Rigel DS, Friedman RJ, Levenstein MJ, Gumport SL, Henessey P (1987) Thickness of malignant melanoma: global analysis of related factors. J Dermatol Surg Oncol 13:345–420
Kornstein MJ, Brooks JSJ, Elder DE (1983) Immunoperoxidase localisation of lymphocyte subsets in the host response to melanoma and naevi. Cancer Res 43:2749–2753
Mascaro JM, Molgo M, Castel T, Castro J (1987) Plasma cells within the infiltrate of primary cutaneous malignant melanoma of the skin. Am J Dermatopathol 9:497–499
McGovern VJ, Shaw HM, Milton GW (1983) Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology 7:673–680
Naruns PL, Nizze A, Cochran AJ, Lee MB, Morton DL (1986) Recurrence potential of thin primary melanomas. Cancer 57:545–548
Ronan SG, Eng AM, Briele HA, Shioura NN, Das Gupta TK (1987) Thin malignant melanomas with regression and metastases. Arch Dermatol 123:1326–1330
Sagebiel R (1985) Regression and other factors of prognostic interest in malignant melanoma (editorial). Arch Dermatol 121:1125–1126
Schmoeckel C, Bockelbrink A, Bockelbrink H, Braun-Falco O (1983) Low and high risk malignant melanoma. II. Multivariate analyses for a prognostic classification. Eur J Cancer Clin Oncol 19:237–243
Shaw HM, McCarthy SW, McCarthy WH, Thompson JF, Milton GW (1989) Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases. Histopathology 15:257–265
Simony J, Rossi JF, Shishehian B, Ursule E, Radal M, Pujol H (1991) Characterization of proliferative cells in malignant melanomas and their inflammatory infiltrates. Cancer Detect Prevent 15 3:183–187
Slingluff CL, Vollmer RT, Reintgen DS, Seigler HF (1988) Lethal “thin” malignant melanoma. Identifying patients at risk. Ann Surg 208 2:150–161
Sondergaard K, Schou G (1985) Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. Virchows Arch [A] 406:179–195
Tefany FJ, Barnetson RStC, Halliday GM, McCarthy SW, McCarthy WH (1991) Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol 97:197–202
Trau H, Rigel DS, Harris MN, Kopf AW, Friedman RJ, Gumport SL, Bart RS, Robson W, Grier N (1983) Metastases of thin melanomas. Cancer 51:553–556
Wanebo HJ, Cooper PH, Ward Hagar R (1985) Thin (less than 1 mm) melanomas of the extremities are biologically favourable lesions not influenced by regression. Ann Surg 201 4:499–504
Yonemoto RH, Paladugu RR (1983) Biologic behaviour of thin malignant melanomas with regressive changes. Arch Surg 118:41–44
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cook, M.G. The significance of inflammation and regression in melanoma. Vichows Archiv A Pathol Anat 420, 113–115 (1992). https://doi.org/10.1007/BF02358800
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02358800